- recruitingPHASE2
ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids
This study looks at adding a cannabis-based medicine (Nabiximols) to standard treatment (Temozolomide) for a type of brain tumour called glioblastoma that has come back. It aims to see if this combination works better than standard treatment alone.
United Kingdom - recruitingPHASE1, PHASE2
Modulation of THC Effects by CBD: a Dose-ranging Study
This study looks at how different amounts of CBD affect the mind-altering (psychoactive) effects of THC, the main active part of cannabis. Researchers want to understand if CBD can change how THC makes people feel, both for safety and for better guidelines.
Canada - active not recruitingPHASE1
The Pharmacokinetics of Single Dose Oral Tetrahydrocannabinol and Cannabidiol
This study looks at how your body handles cannabis components (THC and CBD) when taken by mouth. It includes healthy people and those with kidney disease, including those on dialysis, to understand how kidney health affects these compounds.
Canada